Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 12.8% in August

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) saw a large growth in short interest in August. As of August 31st, there was short interest totalling 14,100 shares, a growth of 12.8% from the August 15th total of 12,500 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 6,000 shares, the short-interest ratio is currently 2.4 days.

Anebulo Pharmaceuticals Trading Down 0.5 %

Shares of NASDAQ:ANEB traded down $0.01 on Monday, reaching $2.08. 2,300 shares of the company were exchanged, compared to its average volume of 5,792. The company has a 50-day moving average of $2.09 and a 200-day moving average of $2.39. The firm has a market cap of $53.94 million, a price-to-earnings ratio of -5.62 and a beta of -1.01. Anebulo Pharmaceuticals has a 1-year low of $1.62 and a 1-year high of $3.71.

About Anebulo Pharmaceuticals

Anebulo Pharmaceuticals, Inc, a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI.